Biocept Obtains $3,600,000 New Financing Round

  • Feed Type
  • Date
    3/30/2010
  • Company Name
    Biocept
  • Mailing Address
    5810 Nancy Ridge Drive San Diego, CA 92121
  • Company Description
    Biocept is an emerging leader in genetic testing. The company’s proprietary CEE Cell Enrichment and Extraction technology is designed to isolate and extract rare cells for highly accurate genetic analysis. CEE will be used exclusively in Biocept Laboratories’ first product, preCEEd” prenatal diagnostic. This in-house-developed test will be performed in Biocept’s CLIA certified laboratory. preCEEd will enable reliable first-trimester diagnosis with the ease of a cervical swab.
  • Website
    http://www.biocept.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $3,600,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy